000 | 01961 a2200541 4500 | ||
---|---|---|---|
005 | 20250513230001.0 | ||
264 | 0 | _c20010104 | |
008 | 200101s 0 0 eng d | ||
022 | _a0896-6273 | ||
024 | 7 |
_a10.1016/s0896-6273(00)00128-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aXia, J | |
245 | 0 | 0 |
_aCerebellar long-term depression requires PKC-regulated interactions between GluR2/3 and PDZ domain-containing proteins. _h[electronic resource] |
260 |
_bNeuron _cNov 2000 |
||
300 |
_a499-510 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdaptor Proteins, Signal Transducing |
650 | 0 | 4 |
_aAmino Acid Motifs _ximmunology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies _xpharmacology |
650 | 0 | 4 |
_aBinding, Competitive _xdrug effects |
650 | 0 | 4 |
_aCalcium _xmetabolism |
650 | 0 | 4 |
_aCarrier Proteins _xgenetics |
650 | 0 | 4 | _aCell Cycle Proteins |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCerebellum _xcytology |
650 | 0 | 4 |
_aExcitatory Postsynaptic Potentials _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNerve Tissue Proteins _xmetabolism |
650 | 0 | 4 |
_aNeural Inhibition _xdrug effects |
650 | 0 | 4 |
_aNeuronal Plasticity _xdrug effects |
650 | 0 | 4 |
_aNuclear Proteins _xgenetics |
650 | 0 | 4 | _aPatch-Clamp Techniques |
650 | 0 | 4 |
_aPeptide Fragments _xmetabolism |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aProtein Kinase C _xmetabolism |
650 | 0 | 4 |
_aProtein Structure, Tertiary _xphysiology |
650 | 0 | 4 |
_aPurkinje Cells _xcytology |
650 | 0 | 4 |
_aReceptors, AMPA _xmetabolism |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xgenetics |
650 | 0 | 4 | _aTime |
700 | 1 | _aChung, H J | |
700 | 1 | _aWihler, C | |
700 | 1 | _aHuganir, R L | |
700 | 1 | _aLinden, D J | |
773 | 0 |
_tNeuron _gvol. 28 _gno. 2 _gp. 499-510 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0896-6273(00)00128-8 _zAvailable from publisher's website |
999 |
_c11084379 _d11084379 |